FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/06/2026
Voltar para busca
Dado oficial do USPTO
INDIVUMED THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
30/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 42, 44
Data de depósito
22/02/2024
Data de registro
31/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/03/2026
Última transação
30/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
27
Localização do titular
DE
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the term "INDIVUMED" in blue letters above the term "THERAPEUTICS" in smaller blue letters. To the left of the terms is a design of a blue circle with a smaller red circle overlaying the topright portion, there is a white space between the circles.
Titulares e representantes
Titulares
Indivumed GmbH
Representantes
R. Glenn Schroeder Schroeder Law PC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticaltherapeutic and veterinary preparationsin particular medicines for human beings and animals for the treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; human and animal sample materialsfor medical purposesAllograft or Xenograft tissue preparationstissue cutsblood plasmablood serumascitescerebrospinal fluidhuman and animal urine and human and animal stool; test kits of human and animal samples materials for medical purposes comprising medical diagnostic reagents for medical diagnostic purposes; therapeutic preparations for the treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune systemmade using molecular biologicalmolecular geneticgenetic engineeringimmunological and biotechnical methods; medical diagnostic reagents; clinical diagnostic reagents for medical use; medical diagnostic test strips for blood analysis and urine analysis; diagnostic preparations and materials for medical or veterinary purposes; diagnostic reagents for medical use; diagnostic substances for medical use; biological material collectionsbiological tissue samplesblood plasma samples and blood serum samples for medical purposes; cancer material collectionsbiological tissue samplesblood plasma samples and blood serum samples for cancer diagnosis and treatment purposes; medical sample collections; biological sample collectionsbiological tissue samplesblood plasma samples and blood serum samples for medical purposes; biopsy material collectionsbiological tissue samples; all the afore-mentioned in particular with regard to the field of oncology
Classe 9
Apparatus and instruments for scientific research in laboratoriesin particular apparatus for analysis of biologic samples and for the qualitative and quantitative recognition of analytes in samplesthe identification of sample typeselectronic analysers and analysers for the qualitative and quantitative recognition of samples and identification of the sample type and molecular states; apparatus for the typing of tissues and tissue samplesnamely for the molecular analysis of biological samples such as tissuecutsbloodserumplasmaascitescerebrospinal fluidurine or stool; apparatus for recordingtransmission or reproduction of datahard disk drivesblank hard computer discssolid-state drivesUSB hardware; blank magnetic data carriersdata processing equipment and computers
Classe 42
Scientific and technological servicesscientific research and design for others in the field of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; research services in the field of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; design and development of computer hardware and softwarein particular computer programs; scientific research for medical purposesin particular molecular biologicalimmunological and histological laboratory servicesin particular research and development in the field of human medical and veterinary medical diagnostics and therapy; typing of tissue and tissue samplesin particular using molecular biologicalimmunologicalgenetic engineering and histological methods for research purposes; collection of human and animal biospecimen and clinical data for the diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; generation ofby means of scientific computer-aided sample analysisprovision ofby means of cloud storage and online access of multi-omics data from human and animal biospecimenin particular genomicepigenomicproteomicphosphorproteomicRNAtranscriptomiclipidomic and metabolomic data for the diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; medical research laboratory servicestyping of tissue and tissue samplesin particular using molecular biologicalimmunologicalgenetic engineering and histological methods; database design and development; providing online non-downloadable computer software platforms for hosting databases; installationmaintenance and updating of database software; providing scientific research information and results in the field of diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system from an online searchable database; programming of databases; collecting geneticmedicalbiomedicalbiologicchemical and biochemical data and informationin particular information generated through the use of imaging techniquesthe use of liquid biopsy methodsthe use of histopathological analysis and proceduresthe use of genetic analysis and the use of genomicsproteomicstranscriptomicsmetabolomicslipidomics and/or glycomics studies and analysis for medical research; scientific and laboratory analysis using bioinformatics and computational biology in the field of diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; consultancy relating to research and development in the field of therapeutics and pharmaceutics; pharmaceutical and therapeutical products development; pharmaceutical research and development services; research and development for the pharmaceutical and biotechnological industry; services for research and development in the pharmaceutical and biotechnical field; services for research and development regarding pharmaceuticstherapeuticsdiagnosticsespecially for the medical examination and medical care of patients
Classe 44
Medical analysis in connection with the treatment of individualsmedical analysis of X-rays and blood samplesmedical testing for diagnostic and treatment purposes; provision of analysis files which provide medical information to medical and scientific personnel and allows members to update their medical treatment or scientific research plans; medical clinic services; pharmaceutical advisory services; medical analysis services using bioinformatics and computational biologyfor patient diagnostic and treatment purposes; providing supporting services and advice to hospitals and other medical care centerscollecting and stabilizing of human and animal biospecimensthe collection of related clinical data for patient diagnostic and treatment purposes; all the afore-mentioned in particular with regard to the field of oncology
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
31/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/02/2026
PUBO
PUBLISHED FOR OPPOSITION
10/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/01/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
20/01/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/01/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
20/01/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
19/09/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/09/2025
GNFR
FINAL REFUSAL E-MAILED
03/09/2025
CNFR
FINAL REFUSAL WRITTEN
03/09/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/09/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2025
GNRT
NON-FINAL ACTION E-MAILED
06/02/2025
CNRT
NON-FINAL ACTION WRITTEN
06/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/12/2024
RFNT
REFUSAL PROCESSED BY IB
19/10/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/09/2024
RFRR
REFUSAL PROCESSED BY MPU
27/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/09/2024
CNRT
NON-FINAL ACTION WRITTEN
24/09/2024
DOCK
ASSIGNED TO EXAMINER
11/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/04/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INDIVUMED THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.